Search for Clinical Trial Results

Sponsored By

Acute Promyelocytic Leukemia - 35 Studies Found

Status Study
Completed Study Name: Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL
Condition: Acute Promyelocytic Leukemia
Date: 2007-08-21
Interventions: Drug: Tamibarotene For induction therapy, tamibarotene will be self-administered via tablets on an outpa
Recruiting Study Name: Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia
Condition:
  • Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA
  • Drug: Arsenic Trioxide Given I
Terminated Study Name: ASCT for Relapsed APL After Molecular Remission
Condition:
  • Acute Promyelocytic Leukemia
  • Relapse

Date: 2009-05-21
Interventions: Procedure: autologous hematopoietic cell transplantation A
Completed Study Name: Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia
Condition:
  • Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)
  • Adult Acute Promye
    Date: 1999-11-01
    Interventions:
    • Drug: tretinoin Given orally
Completed Study Name: Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia
Condition: Acute Promyelocytic Leukemia
Date: 2010-10-20
Interventions:
  • Drug: ATRA see the protocol
Completed Study Name: National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup
Condition:
  • Newly-diagnosed APL (de Novo or Therapy-related)
  • Relapsed APL

Date: 2014-07-11
Interventions: Other: observational
Enrolling by invitation Study Name: A Study for Improving the Outcome of Childhood Acute Promyeloid Leukemia
Condition: Childhood Acute Promyelocytic Leukemia
Date: 2014-02-08
Interventions:
  • Drug: ATO Given IV

Recruiting Study Name: Acute Promyelocytic Leukemia (APL) Treated With ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin
Condition: Leukemia
Date: 2011-08-02
Interventions:
  • Drug: ATRA 45 mg/m2 daily by m
Completed Study Name: Cytarabine (Ara-C) in Children With Acute Promyelocytic Leukemia (APL)
Condition: Leukemia
Date: 2010-08-18
Interventions: Drug: Ara-c Drug: ATRA 25mg/m2 day until complete remissio
Completed Study Name: Comparison of Two Treatments in Intermediate and High-risk Acute Promyelocytic Leukemia (APL) Patients to Assess Efficacy in 1st Hematological Complete Remission and Molecular Remission
Condition: Leukemia, Myelocytic, Acute
Date: 2009-08-18
Interventions:
  • Drug: gemtuzumab ozogamicin 2

<<< Previous | Next >>>